Clinical Trial Update: Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the safety and immunogenicity of the placental malaria vaccine candidate PAMVAC with various adjuvants in antepartum malaria; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria in Pregnancy

Drugs mentioned

• PAMVAC (Placental malaria vaccine candidate PAMVAC)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Malaria, Antepartum | Phase 1 | Status: COMPLETED